Other languages Sirio Pharma Co., Ltd.

Equities

300791

CNE100003NB0

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-29 pm EDT			5-day change	1st Jan Change
38.86 ^CNY	-1.52%		-1.92%	+12.12%

Apr. 21	Sirio Pharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 19	Tranche Update on Sirio Pharma Co., Ltd.'s Equity Buyback Plan announced on September 15, 2023.	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sirio Pharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 20
Tranche Update on Sirio Pharma Co., Ltd.'s Equity Buyback Plan announced on September 15, 2023.	Mar. 19
Sirio Pharma Co., Ltd.'s Equity Buyback announced on September 15, 2023, has closed with 1,285,600 shares, representing 0.71% for CNY 39.9 million.	Mar. 17
Tranche Update on Sirio Pharma Co., Ltd.'s Equity Buyback Plan announced on September 15, 2023.	Jan. 02
Sirio Pharma Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-25
Certain A-Shares of Sirio Pharma Company Limited are subject to a Lock-Up Agreement Ending on 25-SEP-2023.	23-09-24
Sirio Pharma Co., Ltd.(XSEC:300791) added to S&P Global BMI Index	23-09-18
Sirio Pharma Co., Ltd. announces an Equity Buyback for CNY 40 million worth of its shares.	23-09-15
Sirio Pharma Co., Ltd. authorizes a Buyback Plan.	23-09-13
Sirio Pharma Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-24
Sirio Pharma Co., Ltd. Announces Implementation of Cash Dividend for the Year 2022, Payable on June 07, 2023	23-06-01
Sirio Pharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-27
Sirio Pharma Co., Ltd. Proposes Profit Distribution Proposal of Cash Dividend for the Year 2022	23-04-21
Sirio Pharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-20
Sirio Pharma Co., Ltd.(XSEC:300791) dropped from S&P Global BMI Index	22-12-19
Sirio Pharma Cancels Planned 1.35 Billion Yuan Share Sale to Fund Aquisition	22-12-08
Sirio Pharma Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-25
Sirio Pharma Co., Ltd. acquired 80% stake in Best Formulations Inc. from m Eugene C. Ung, Kelly C. Ung, Charles C. Ung, Peak Trust Company-NV, Jeffrey A. Goh, and Joy S. Hsu.	22-10-16
Certain A-Shares of Sirio Pharma Company Limited are subject to a Lock-Up Agreement Ending on 25-SEP-2022.	22-09-24
Sirio Pharma Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-25

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Sirio Pharma Co., Ltd.

Equities

300791

CNE100003NB0

Other languages

Filters